Verena Häfner

421 total citations
8 papers, 316 citations indexed

About

Verena Häfner is a scholar working on Nephrology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Verena Häfner has authored 8 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 3 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Verena Häfner's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antifungal resistance and susceptibility (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Verena Häfner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antifungal resistance and susceptibility (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Verena Häfner collaborates with scholars based in Germany, Austria and United States. Verena Häfner's co-authors include Heike L. Rittner, Piotr Adrian Klimiuk, Cornelia M. Weyand, Luke I. Szweda, Jörg J. Goronzy, Gerd Mikus, Walter E. Haefeli, Jürgen Burhenne, Thomas Weinreich and Jürgen Bommer and has published in prestigious journals such as Journal of Clinical Investigation, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

Verena Häfner

8 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Verena Häfner Germany	6	82	79	52	45	38	8	316
Xiulan Su China	9	97 1.2×	87 1.1×	10 0.2×	24 0.5×	29 0.8×	26	327
Noriko Kohyama Japan	13	21 0.3×	204 2.6×	26 0.5×	66 1.5×	108 2.8×	34	628
Qianzhou Lv China	13	14 0.2×	112 1.4×	56 1.1×	35 0.8×	18 0.5×	41	428
Toshio Kubota Japan	12	15 0.2×	97 1.2×	27 0.5×	25 0.6×	14 0.4×	29	412
Akinori Soejima Japan	10	42 0.5×	171 2.2×	8 0.2×	25 0.6×	40 1.1×	21	360
Surafel Mulugeta United States	10	23 0.3×	160 2.0×	29 0.6×	283 6.3×	41 1.1×	10	505
Lata Kaphalia United States	13	32 0.4×	137 1.7×	6 0.1×	35 0.8×	20 0.5×	27	456
Pablo Solís‐Muñoz Spain	12	39 0.5×	160 2.0×	30 0.6×	18 0.4×	11 0.3×	22	451
Weifeng Hu China	12	15 0.2×	181 2.3×	23 0.4×	32 0.7×	11 0.3×	30	445
Luis Gómez-Cambronero Spain	8	14 0.2×	103 1.3×	18 0.3×	30 0.7×	11 0.3×	8	369

Countries citing papers authored by Verena Häfner

Since Specialization

Citations

This map shows the geographic impact of Verena Häfner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Häfner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Häfner more than expected).

Fields of papers citing papers by Verena Häfner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Häfner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Häfner. The network helps show where Verena Häfner may publish in the future.

Co-authorship network of co-authors of Verena Häfner

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Häfner. A scholar is included among the top collaborators of Verena Häfner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Häfner. Verena Häfner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Häfner, Verena, Barbara Grün, Christoph Markert, et al.. (2010). Arzneimittelinteraktionen. Der Internist. 51(3). 359–370. 2 indexed citations

Häfner, Verena, David Czock, Jürgen Burhenne, et al.. (2010). Pharmacokinetics of Sulfobutylether-Beta-Cyclodextrin and Voriconazole in Patients with End-Stage Renal Failure during Treatment with Two Hemodialysis Systems and Hemodiafiltration. Antimicrobial Agents and Chemotherapy. 54(6). 2596–2602. 61 indexed citations

Häfner, Verena, Michael Jäger, Reinhard Ding, et al.. (2009). Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity. Clinical Pharmacology & Therapeutics. 87(2). 191–196. 41 indexed citations

Heinrich, T., Verena Häfner, H. Schmidt-Gayk, et al.. (2008). Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function. Nephrology Dialysis Transplantation. 23(9). 2861–2867. 11 indexed citations

Häfner, Verena, Rui Ding, T. Heinrich, et al.. (2008). Calcium balance during calcitriol and paricalcitol administration in healthy humans. International Journal of Clinical Pharmacology and Therapeutics. 46(3). 131–135. 2 indexed citations

Häfner, Verena, et al.. (2008). Inhibition of Voriconazole Metabolism by Chloramphenicol in an Adolescent with Central Nervous System Aspergillosis. Antimicrobial Agents and Chemotherapy. 52(11). 4172–4174. 9 indexed citations

Tzvetkov, Mladen V., Klaus Huse, Bettina Kulle, et al.. (2006). Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 374(1). 21–30. 19 indexed citations

Rittner, Heike L., Verena Häfner, Piotr Adrian Klimiuk, et al.. (1999). Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. Journal of Clinical Investigation. 103(7). 1007–1013. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact